The intensity of expression of MCL1 in both cell lines was overall congruous with Fra-1 expression—that is, low in the primary tumor, with elevated, heterogeneous expression in metastases (Figs. 2A-B and 5C-D). The gene discussed is MCL1; the disease is neoplasm.